REFERENSI
JUNG, Hae Do, et al. Silodosin versus Tamsulosin for Medical Expulsive Therapy of Ureteral stones: an updated systematic review and Meta-analysis of Randomized controlled trials. Medicina, 2022, 58.12: 1794.
KAPLAN, Steven A. Benign prostatic hyperplasia. Journal of Urology, 2021, 206.2: 447-450.
AMANI, Behnam, et al. Combination therapy with Tamsulosin plus Dutasteride Versus Tamsulosin in Benign Prostatic Hyperplasia: a Systematic review & Meta-analysis. Journal of Pharmacoeconomics and Pharmaceutical Management, 2022, 8.4: 7-15
PLOCHOCKI, Alexander; KING, Benjamin. Medical treatment of benign prostatic hyperplasia. Urologic Clinics, 2022, 49.2: 231-238.
RETNAYYAN, APARNA, et al. Comparison of efficacy of tamsulosin, alfuzosin, and silodosin in the management of benign prostatic hyperplasia. Asian J Pharm Clin Res, 2023, 16.2: 138-142.
ELTERMAN, Dean, et al. UPDATE–Canadian Urological Association guideline: Male lower urinary tract symptoms/benign prostatic hyperplasia. Canadian Urological Association Journal, 2022, 16.8: 245.
